Robert Kaminsky, MBA

Exploring how health plans and hemophilia treatment centers can better work together to deliver high-quality care and manage costs associated with hemophilia.

In September 2009, the Pharmacy & Therapeutics Society gathered a study group of 12 managed care medical and pharmacy directors. The objective was to examine the impact that biomarker-based assays could have on the approaches payers and providers use to manage cancer.